ABCDx specializes in the discovery, clinical validation and commercialization of brain mobile diagnostic solutions with advanced blood-based biomarkers through it proprietary
Software as a Medical Device platform

About the founders

Prof. Sanchez & Dr Montaner Villalonga are recognized as Key Opinion Leaders in the field of brain biomarkers. They combine their unique expertise in brain biomarker discovery, awareness and clinical validation.

Their continuous discoveries of novel brain biomarkers constitute the IP portfolio of ABCDx and allow a rapid access to clinical validation for ABCDx’s medical devices.